Boulder, CO, United States of America

Michael Stowell

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Michael Stowell in Therapeutic Compounds

Introduction

Michael Stowell is an accomplished inventor based in Boulder, Colorado. He has made significant contributions to the field of medicinal chemistry through his innovative research and development of novel therapeutic compounds. His work focuses on the synthesis of shape-shifting cyclic peptides, which have the potential to revolutionize drug design.

Latest Patents

Stowell holds a patent for "Compositions and methods of synthesizing shape shifting cyclic peptides (SSCP) and their use in the identification of novel therapeutic compounds." This invention presents a groundbreaking platform for developing drug-like compounds that can interconvert between multiple chemical structures. These compounds possess varying pharmacophore properties, allowing for enhanced therapeutic applications.

Career Highlights

Stowell's career is marked by his dedication to advancing the field of drug discovery. His innovative approach to synthesizing bullvalene amino acid (Bvas) compounds has opened new avenues for creating shape-shifting cyclic peptides. These peptides are designed to overcome physical mass limitations, making them a promising area of research in therapeutic development.

Collaborations

Throughout his career, Stowell has collaborated with notable colleagues, including William Old and Brady Worrell. These partnerships have fostered a collaborative environment that enhances the research and development of novel therapeutic compounds.

Conclusion

Michael Stowell's contributions to the field of medicinal chemistry through his innovative patent and collaborative efforts highlight his role as a leading inventor in the development of novel therapeutic compounds. His work continues to pave the way for advancements in drug design and therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…